Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204 - Tawbi, H; Forsyth, P; Algazi, A (J Clin Oncol, 2017)
et al.